Epicrispr Biotechnologies
PrivateLast Round
Series C
Aug 11, 2026
Est. Valuation
$95.14M
Total Funding Raised
$213M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Epicrispr Biotechnologies is a biotechnology company developing gene-modulating therapies using its proprietary Gene Expression Modulation System (GEMS) to treat a range of genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epicrispr Biotechnologies Comparables
Compare Epicrispr Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tune Therapeutics | 84% | |
| Moonwalk Biosciences | 84% | |
| Chroma Medicine | 83% | |
Epicrispr Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 11, 2026 | ||||
| Series B | Mar 26, 2025 | ||||
| Series A | Jul 12, 2022 |
Epicrispr Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series C |
| Horizons Ventures | Series A |
| abrdn Inc. | Series C |
| Ally Bridge Group | Series B |
| Readout Capital | Series C |
| Cormorant Asset Management | Series C |
| Duquesne Family Office | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 11, 2026
$90M round led by Janus Henderson Group and Octagon Capital Advisors.
- Jul 27, 2026
Monthly visitors increased 68% MoM.
Epicrispr Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Epicrispr Biotechnologies's valuation, stock price, and market status.